Sep 06, 2023 / 02:30PM GMT
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP
All right, welcome. Thank you everyone. It's a pleasure here to host Steve Harr, CEO of Sana Biotechnology. Steve, thank you for being with us today.
Steven D. Harr - Sana Biotechnology, Inc. - President, CEO & Director
(inaudible).
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP
I want to if both mics working.
Steven D. Harr - Sana Biotechnology, Inc. - President, CEO & Director
Can you hear me now? There we go.
Questions and Answers:
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VPAll right. Great. Well, then maybe you can just start us off for those that are a little bit less familiar with Sana, and just giving maybe a 2-minute high-level overview of the company, what you do, where you're working towards.
Steven D. Harr - Sana Biotechnology, Inc. - President, CEO & Director